The STOP COVID 2 study: Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully-remote randomized controlled trial
Reiersen et al., Open Forurm Infectious Diseases, doi:10.1093/ofid/ofad419 (results 8/20/2021)
https://c19early.org/reiersen.html